This announcement is a separate document:
日東紡績：コーポレート・ガバナンスに関する報告書 2024/04/01
Nitto Boseki: Corporate Governance Report 2024/04/01
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Related Stocks Related Stocks
Symbol Mini Chart Latest Price
Unlock the Full List
Latest
16:19
The Passenger Vehicle market retail from December 1 to 8 was 0.502 million units, representing a 32% increase compared to the same period last December.
16:19
Modern Pharmaceuticals: The holding subsidiary Sinopharm Zhijun has obtained the Pharmaceutical registration certificate for Cefoperazone and Sulbactam Tablets.
16:18
Financial market Analyst Kyle Rodda from Capital.com anticipates the USA's November CPI: The expected CPI data essentially paves the way for the Fed to cut rates next week, which could be the catalyst for Gold that we need to see.
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.